tirzepatide for menopause Postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a drug overweight and obesity treatment, according to a new study led by Mayo Clinic. ⁣ ⁣ The Women taking hormone therapy lost

Natasha Devon, a body image and mental health campaigner, said the arrival of the drugs would not help alleviate the already problematic pressure on people who are obese

Recent analyses have raised questions about psychiatric side effects, particularly mood changes and anxiety. Patients with asthma may be at increased risk of respiratory complications, and nutrient deficiencies can occur with long-term therapy. Monitoring mental health and nutritional status should be part of any GLP-1 program

ISO/IEC 17025-Accredited Laboratory Release Release decisions move to a third-party laboratory holding ISO/IEC 17025 accreditation, operating under separate management from the synthesis facility

& Hammond, C